Data on the individual and collective impact of chronic airflow obstruction at a population level are scarce. In a nationwide survey, dyspnea, quality of life, and missed working days were compared between subjects with and without spirometrydiagnosed chronic airflow obstruction.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mortality, handicap and health care costs worldwide [1, 2] . Prevalence is high, ranging from 4% to 10% [3] , but the disease remains largely under-diagnosed [4, 5] [6] . This may relate to the relatively late occurrence and underestimation of symptoms [7] , which correlate poorly with lung function [8] .
COPD alters quality of life, mainly through dyspnea and exacerbations, and is associated with several extra-respiratory manifestations [9, 10] . Ultimately, it leads to respiratory failure and premature death. Based on these assumptions, guidelines advocate the need for early detection of the disease, to (i) motivate patients towards smoking cessation [11] and (ii) allow the use of treatments that can reduce the impact of COPD on symptoms, activities, quality of life and healthcare costs [1, 2, 12, 13] . However, this impact has been seldom evaluated at the general population level:
in most cases, subjects recruited in quality of life studies were patients with known COPD, which excludes the most prevalent fraction of the diseased population, i.e., the less severe and undiagnosed cases. Thus, it is difficult to estimate the global consequences of the disease on health status in the population, and the possible effect of early detection at this level.
The present analysis was designed to assess the impact of chronic airflow obstruction on dyspnea, quality of life (measured with a generic questionnaire) and missed working days in a population sample, which was constituted with the primary objective of determining the prevalence of chronic airflow obstruction [14] .
MATERIAL AND METHODS

Study design
Subjects were recruited in 31 health prevention centres which are accessible to all workers. The sample was built according to national statistics on age and sex distribution in the general population of the considered age range (subjects aged 40 years and more). Subjects filled a standardized auto-questionnaire and a technician who was not aware of answers to the questionnaire measured FEV 1 and FVC. All subjects received an information note before their participation.
Questionnaire and spirometry
Data obtained from each individual included usual demographic and anthropometrical description, information on risk factors, clinical symptoms, associated chronic diseases and presumptive diagnosis, and previous assessment of lung function.
The questionnaire was derived from the European Community Respiratory Health Survey (ECRHS) questionnaire [15] . Details on its content have already been published. Dyspnoea was measured using the 0-4 modified MRC scale and quality of life was assessed using a generic 5-dimension questionnaire, EuroQOL 5D [16] .
Declared missed working days during the previous year were recorded.
Spirometry was performed pre-bronchodilator by trained technicians using dailycalibrated spirometers. Three measures were performed, the best technically adequate being chosen for analysis. Subjects were excluded from the analyses when only one spirometric measurement was adequate or when the variation between the two highest FEV 1 values exceeded 200 ml. Predicted values were calculated using ERS equations [17, 18] . Airflow obstruction was defined by a FEV 1 /FVC ratio <0.70.
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Statistical analysis
The study was powered to assess the prevalence of chronic airflow obstruction in the population. Considering the expected prevalence of airflow obstruction at about 5%, an allowed risk of error of 0.5% of this percentage, and a possible analysis on 2 strata, 4500 individuals had to be recruited for the survey.
Analysis were performed using SAS software (SAS Institute, Cary, NC, USA).
Results are expressed as percentages or means + one standard deviation.
Based on questionnaire data, analyses were performed in three populations: the whole population, non asthmatics and subjects with no declared respiratory or cardiac disease.
In each of these populations, percentages have been compared by two-way and multiway frequency analysis, and means by analysis of variance and t-tests.
Relations between continuous variables were assessed using linear regression. A difference was considered significant if p<0.05. Bonferroni corrections were performed for multiple comparisons.
Finally, multivariate logistic regression analyses were performed to identify independent predictors of quality of life and work loss. For these analysis, dependent variables were (i) scores of each EQ-5D domain and (ii) presence or absence of at least one missed working day, respectively. This last analysis was restricted to the active fraction of the population, i.e. subjects aged<65 years.
RESULTS
Characteristics of the studied population (table 1)
A total of 5008 subjects were included in the survey during an 8-month recruitment period; this corresponded to a 93.5% response rate among subjects initially asked to participate. Adequate questionnaire and spirometry data were available in 4764 subjects (95.1%). Mean age was 60 years; 81% of subjects were less than 70 years of age and only 2% were more than 80 years old. Already known chronic respiratory diseases were reported by 9.1% of subjects for asthma, 2.6% for COPD and 5.8% for chronic bronchitis. Questions on symptoms found that chronic bronchitis was actually present in 3.9% of subjects. Prevalence of chronic airflow obstruction in nonasthmatics was 7.5%. In the majority of these patients (FEV 1 ≥80% predicted: 59%), the severity of airflow obstruction was mild and chronic bronchitis was absent.
Severity of airflow obstruction was moderate (FEV 1 [50-80]% predicted) in 36.1%, severe or very severe (FEV 1 <50% predicted) in 4.8%. Among non-asthmatic subjects in whom airflow obstruction was found, only 6.1% had been previously diagnosed as having a chronic respiratory disease.
Impact of chronic airflow obstruction: dyspnoea, quality of life
In the whole population and in subjects with no known heart or lung disease, dyspnoea grade correlated significantly (p<0.0001) but weakly (r=0.28) with EQ-5D visual analogic scale score. There were also significant relationships between dyspnoea grade and EQ-5D sub-scores (mobility, activity, anxiety, autonomy and pain: all, p<0.001; data in the whole population are shown in table 2).
Altogether, 7.2% of subjects with dyspnoea grade 0 had airflow obstruction versus 10.7% of those with dyspnoea grade ≥ 1, 14.8% of those with dyspnoea grade ≥ 2 and 21.8% of those with dyspnoea grade = 4.
In subjects without known chronic respiratory or heart disease, but who were diagnosed as actually having airflow obstruction during the examination, severity of dyspnea increased with that of airflow obstruction (figure 1).
In the whole population, patients who declared having asthma, COPD or chronic heart failure had lower aggregated EQ-5D scores than controls, all domains of the questionnaire being affected (data not shown). In patients with no chronic respiratory or cardiac disease, scores on EQ-5D visual analogic scale decreased with FEV 1 % pred (mean score 70.5 ± 14.8 vs 72.8 ± 14.8 in subjects with versus without aiflow obstruction, p=0.004) while, in all EQ-5D domains, airflow obstruction was associated with lower proportions of patients declaring no limitation than in subjects with no airflow obstruction : 87% versus 93% for mobility, 97% versus 99% for autonomy; 90% versus 93% for activity, 38% versus 46% for pain and 49% versus 55% for anxiety (all, p<0.05). Multivariate analysis showed that age and FEV 1 were independent predictors of all EQ-5D domains except anxiety, which was mainly influenced by gender (table 3) .
Missed working days
The number of missed working days was significantly associated with (i) health status, as measured by EQ-5D visual analogic scale and all EQ-5D domains except autonomy and (ii) dyspnoea grade (data not shown; p<0.01 for all analysis).
On average, most subjects reported no missed working day during the year preceding the examination (figure 2). However, in all groups (whole population, nonasthmatics, subjects with no declared respiratory or cardiac disease) a decreased FEV 1 /FVC ratio was associated with an increase in missed working days (subjects with no respiratory or heart disease: 6.71 ± 39.09 vs 1.45 ± 14.33; p=0.0015). In the 10/01/2008 whole population and in non-asthmatics, number of missed working days was higher in subjects reporting symptoms of chronic bronchitis than in other subjects (5.56 ± 15.45 vs 1.75 ± 16.54, p=0.05) and patients with a FEV 1 between 50% and 80% predicted missed more working days than those with a FEV 1 ≥100% predicted (4.62 ± 32.80 vs 1.54 ± 13.90; p=0.04). These differences were not significant in nonasthmatics declaring no co-morbid respiratory or cardiac disease. Other differences between FEV 1 categories were also not significant. In multivariate analysis, chronic bronchitis was the only independent predictor of missed working days (p<0.0001, OR: 95% CI: ) (table 3) , and interacted strongly with airglow obstruction (test for interaction: p<0.001).
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DISCUSSION
In this sample of 4764 subjects visiting health prevention centres, airflow obstruction was present in 7.5% of non-asthmatics and was of mild-to-moderate severity in the vast majority of cases. In these subjects, exertional dyspnea was more frequent, quality of life assessed by the EuroQOL-5D generic questionnaire was poorer and the number of missed working days was greater than in other subjects. The vast majority (93.9%) of subjects with airflow obstruction were not previously known as suffering from any kind of chronic respiratory disease.
Limitations and strengths of the study
To our knowledge, this is one of the largest spirometry-based population study assessing the impact of chronic airflow obstruction, using a validated quality of life questionnaire.
Airflow obstruction was defined according to pre-bronchodilator spirometry, which is not in accordance with current guidelines. However, this was inevitable since French health prevention centres are not allowed to deliver any kind of medication. In addition, the use of pre-bronchodilator values is in line with several recent epidemiological studies such as those by De Marco et al. [15, 19] . In their most recent paper, these authors conclude that the use of pre-bronchodilator values exposes to a risk of overestimating the prevalence of COPD. They also show that this risk is minimized by exclusion of asthmatic subjects. For this reason, all analysis were performed in the whole population, in non asthmatics only and in subjects with no known heart or respiratory disease. Regarding FEV 1 /FVC ratio, the use of the fixed 0.70 cut off rather than lower limit of normal to diagnose airflow obstruction may overestimate the prevalence of the disease in the elderly (and underestimate it in younger adults, but these were not part of our study population). However, for practical reasons the fixed cut off is the recommended way of diagnosing chronic airflow obstruction in current guidelines. In addition, elderly subjects and those < 40 years represented a small part of our population, which limits the overall risk of error.
The mode of recruitment was certainly a source of bias: since (i) the main purpose of health examination centres is prevention and (ii) visits to these centres are offered mainly to the working population, subjects of the studied population are less likely to exhibit symptoms or be known as having any disease than the general population ("healthy worker effect"). Accordingly, the proportion of patients with a known diagnosis of COPD (6.1%) was lower than in other studies [4, 5, 20] . Thus, the prevalence and impact of chronic airflow obstruction may be underestimated, which may help explaining the low number of subjects with FEV 1 <50% predicted and the low proportion of subjects with airflow obstruction who reported symptoms of chronic bronchitis, severe dyspnea or a previously known diagnosis of respiratory disease. In addition, the results presented here can not be extrapolated to the non working population. Despite these considerations, overall prevalence data were very similar to that of other studies in developed countries regarding both asthma, chronic bronchitis and airflow obstruction [4, 5, [21] [22] [23] .
Another limitation is the declarative nature of data on work loss. We have no way to assess how this may have affected the results. We can only assume that, since missed working days are important events in the life of workers, they are likely to be remembered accurately enough and not significantly overestimated.
Impact of airflow obstruction
Despite mild severity, patients with chronic airflow obstruction had poorer quality of life and increased dyspnoea and number of missed working days. This observation remained true even in patients with no known heart or lung illness.
Dyspnea
In our patients, quality of life impairment was influenced by dyspnea, although this symptom was much less severe than in patients with possible COPD identified in the Confronting COPD survey [6] : for instance, among persistent smokers with GOLD stage >1 airflow obstruction (in whom dyspnea was the most prevalent), only 8.3%
reported dyspnea grade of 3 or more, whereas the corresponding figure in the Confronting COPD survey was 42.6%. Thus, even mild levels of dyspnea can be associated with impaired quality of life.
Quality of life
In subjects with chronic airflow obstruction identified in the general population, a diagnosis of COPD is more likely when quality of life is more impaired [24] . In addition, lung function is an independent predictor of all EQ-5D domains except anxiety. However, despite the under-representation of severe cases and marked underdiagnosis of COPD in our study, quality of life was impaired by airflow obstruction. In the United States, the National Health and Nutrition Examination Survey also showed that undiagnosed airflow obstruction in the general population is associated with impaired health and functional status. In that study, health status was not assessed using a dedicated questionnaire but with questions about general health status, walking 1/4 mile, lifting or carrying something as heavy as 10 lb, or needing help with personal care [25] . In the Confronting COPD Survey [6] , patients with airflow obstruction also reported activity restrictions related to their respiratory condition: depending on the considered item, 30% to 70% of subjects with or at-risk of COPD reported limitations in sports and recreation, physical exertion, social life, sleep, household chores and sex life. In line with these findings, data from the Spanish EPIDEPOC study found a significant impairment in quality of life measured with the SF-12 questionnaire in stable COPD subjects followed in primary care, even in mild disease stages [26] .
Impact on work COPD is not only a disease of the elderly: its prevalence in subjects aged 65 years or less is not neglectable and has a noticeable impact on resource utilization and health-care costs [27] . In these subjects, ability to work is an important determinant of life satisfaction [28] . In the Confronting COPD survey, 35.7% of patients reported that "their condition prevented them from working, limited their ability to work or had caused them working time loss in the past year". This percentage increased to 45.3% in subjects aged less than 65 years, who were less likely to be part of the 54.8% of the population who were retired [7] . The proportion of retired subjects was much lower in our population (1.3%), which is related to the mode of recruitment: health examination centres target only working subjects. The much lower proportion of subjects reporting work loss in our population is probably related to several factors: slightly younger age (60 years versus 63 years in the Confronting COPD survey), different mode of recruitment (systematic prevention visits by subjects who presume they are healthy versus general population) and studied variable: we used only the number of missed working days to assess disease consequences on work, while Rennard et al. also included reported "limitations in the ability to work" in their assessment; this introduces a possibly more subjective component, the contribution of which is difficult to assess. Finally, we have no way to determine if airflow obstruction was less severe in our population than in the Confronting COPD survey, since lung function was not assessed in that study.
In the National Health and Nutrition Examination Survey (NHANES) III, even patients with spirometry-graded mild COPD were less likely to be in the labor force than controls: more precisely, mild, moderate, and severe COPD was associated with a 3.4%, 3.9%, and 14.4% reduction in the labor force participation rate relative to those without COPD [29] .
Finally, multivariate analysis did not identify lung function as an independent predictor of missed working days while chronic bronchitis was. Thus when the COPD fraction of a population has mostly mild or mild-to-moderate disease, work loss seems to relate more to chronic bronchitis than to airflow obstruction. However, this result has to be taken with some caution since the power of the analysis was relatively low, due to the small number of subjects reporting any missed working day (n=69) among the population restricted to those aged<65 years with no cardiac or respiratory comorbid illness (n=1310). This also prevented us from performing reliable multivariate analysis with the number of missed working days divided in subcategories.
In conclusion, this study in a large sample from health prevention centres found a significant impact of mild-to-moderate airflow obstruction on dyspnea, quality of life and missed working days despite a very low proportion of subjects who spontaneously reported symptoms or a known respiratory disease. Such findings suggest that systematic screening for COPD may be justified in the general population since identified cases suffer from a significant although underestimated impact of the disease, which might be limited by early implementation of preventive and therapeutic measures. <0.0001 § bronchiectasis, chronic heart failure *No independent predictor was found for Mobility class 3 and Activity class 3. # this analysis was restricted to the population aged <65 years, n=1310. Figure 1 : MRC dyspnea grades according to % predicted FEV 1 in subjects with no known heart or lung disease in whom chronic airflow obstruction (FEV1/FVC<0.70) was demonstrated. No subject of this category reported grade 4 dyspnea. Figure 2 : distribution of the number of missed working days reported during the previous year in the population with no known lung or heart disease, according to the presence or absence of chronic bronchitis (top) and airflow obstruction (bottom).
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